Skip to content
Home/Companies/HealthTech/Oto
Oto

Oto

HealthTech·UK·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Oto?

Oto is currently owned by Ryse Asset Management through RYSE Special Opportunities Fund (2024 vintage), since 2022.

Hand-verified · updated 2026-07-07

Ryse Asset Management
Investor
Ryse Asset Management
RYSE Special Opportunities Fund · 2024 · VC

Key facts

HQUnited Kingdom
SectorHealthTech
StatusActive
Websitejoinoto.com

More from RYSE Special Opportunities Fund

Other portfolio companies in the same fund.

Ten63 Therapeutics
Ten63 Therapeutics
Active
BiotechUS· 2026
Braingaze
Braingaze
Active
HealthTechSpain· 2024
Curio Digital Therapeutics
Curio Digital Therapeutics
Active
HealthTechUS· 2024
Knok
Knok
Active
HealthTechPortugal· 2020
Log My Care
Log My Care
Active
HealthTechUK· 2020

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Oto

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Oto?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Oto.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue